|
|||||
|
|
BGG492 as an adjunctive treatment in patients with partial‐onset seizures: A 12‐week,randomized, double‐blind,placebo‐controlled,phase II dose‐titration study with an open‐label extension |
|
| Authors: | Christian E. Elger Seung Bong Hong Christian Brandt Linda Mancione Jackie Han Christine Strohmaier |
| Affiliation: | 1. Department of Epileptology, University of Bonn, Bonn, Germany;2. Department of Neurology, Samsung Medical Center, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Samsung Biomedical Research Institute, Seoul, Korea;3. Bethel Epilepsy Center, Mara Hospital, Bielefeld, Germany;4. Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, U.S.A;5. Novartis Pharma AG, Basel, Switzerland |
| Abstract: | |
| Keywords: | Antiepileptic drugs BGG492 Epilepsy Randomized Open‐label |